CLINICAL_TRIALS
trial_result
· 2017-02-27
Clinical Trial Update: Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity [Phase 3]
Summary
A Phase 3 clinical trial evaluating an occluding dentifrice for dentin hypersensitivity has completed and posted results in February 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Dentin Sensitivity | Phase 3 | Status: COMPLETED | Results posted: 2017-02-27